RxDoctor Payments DataLook up a doctor →

Joseph Beck, MD

Hematology & Oncology · Little Rock, ARNPI 1568441368

Payments from drug & device makers

$260,713in general payments, 2019–2025

Across 937 payments — averaging $278.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • EMD Serono, Inc.$131K
  • Array Biopharma Inc$79K
  • Pfizer$26K
  • Genentech, Inc.$5K
  • AstraZeneca$3K
  • Hoffmann-la Roche Limited$1K
  • plus $16K from 54 others
$67in research payments, 2019–2025

Across 1 payment — averaging $67.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$67

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
EMD Serono, Inc.50$130,667
Array Biopharma Inc30$78,850
Pfizer43$26,380
Genentech, Inc.8$5,041
AstraZeneca(2 entities)51$2,523
Hoffmann-la Roche Limited1$1,495
Merck68$1,140
Bristol Myers Squibb64$1,126
Johnson & Johnson(2 entities)49$976
Astrazeneca UK Limited2$951
Incyte Corporation47$919
Gilead18$820
Novartis41$727
AbbVie28$709
Seagen Inc.30$577
Exelixis Inc.32$557
Genentech USA, Inc.31$525
Lilly USA, LLC21$451
Daiichi Sankyo Inc.23$451
E.r. Squibb & Sons, L.L.C.27$433
Amgen24$384
Viiv Healthcare Company16$346
Sanofi15$328
Eisai Inc.16$326
Astellas Pharma US Inc14$288
Pharmacyclics LLC, An Abbvie Company17$267
GSK13$230
Ipsen Biopharmaceuticals, Inc11$211
AVEO Pharmaceuticals, Inc.10$205
Regeneron Healthcare Solutions, Inc.8$199
Pharmaessentia USA Corporation9$191
Theratechnologies Inc.11$177
Bayer9$166
Beigene USA, Inc.8$153
Puma Biotechnology, Inc.4$151
Janssen Products, LP2$130
Pharmacosmos Therapeutics Inc.8$130
Sobi, Inc6$127
Mirati Therapeutics, Inc.6$116
Takeda Pharmaceuticals U.S.A., Inc.4$91
Clovis Oncology, Inc.6$89
Sumitomo Pharma America, Inc.4$80
Servier Pharmaceuticals LLC3$77
Intuitive Surgical1$77
Morphosys, US Inc.3$70
Epizyme, Inc.5$68
Rigel Pharmaceuticals, Inc.4$67
Beone Medicines USA, Inc.3$66
Boehringer Ingelheim3$63
Foundation Medicine, Inc.3$61
Fresenius Kabi USA, LLC2$48
Blueprint Medicines Corporation2$47
G1 Therapeutics, Inc.3$41
Lexicon Pharmaceuticals, Inc.2$37
Karyopharm Therapeutics Inc.2$32
Caris MPI, Inc.2$30
Stemline Therapeutics Inc.2$27
Kyowa Kirin, Inc.2$24
Global Blood Therapeutics, Inc.1$22
Paratek Pharmaceuticals, Inc.1$22

How this compares

$260,713 in reported general payments places this provider in the 80th percentile of 92 hematology & oncology providers in Arkansas.

See all hematology & oncology providers in Arkansas →

Medicare billing

Part B allowed, 2024
$140,893
Medicare patients
319
Services billed
5,363

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Little Rock

See the full list for Arkansas →

Where these figures come from

Is this you, or does something look wrong? →